For: | Garcia-Gomez A, Sanchez-Guijo F, del Cañizo MC, San Miguel JF, Garayoa M. Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics. World J Stem Cells 2014; 6(3): 322-343 [PMID: 25126382 DOI: 10.4252/wjsc.v6.i3.322] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v6/i3/322.htm |
Number | Citing Articles |
1 |
Nicholas Bingham, Antonia Reale, Andrew Spencer. An Evidence-Based Approach to Myeloma Bone Disease. Current Hematologic Malignancy Reports 2017; 12(2): 109 doi: 10.1007/s11899-017-0370-5
|
2 |
Nicolas Espagnolle, Adélie Balguerie, Emmanuelle Arnaud, Luc Sensebé, Audrey Varin. CD54-Mediated Interaction with Pro-inflammatory Macrophages Increases the Immunosuppressive Function of Human Mesenchymal Stromal Cells. Stem Cell Reports 2017; 8(4): 961 doi: 10.1016/j.stemcr.2017.02.008
|
3 |
Ling Qiu, Lei Ma, Dan Chen, Nan Zhang, Jiao Cai, Qian Zhang, Xiao Wang, Hai Yi, Hao Yao, Fang-Yi Fan. Novel_circ_003686 regulates the osteogenic differentiation of MSCs in patients with myeloma bone disease through miR-142-5p/IGF1 axis. Journal of Bone Oncology 2023; 43: 100509 doi: 10.1016/j.jbo.2023.100509
|
4 |
Vanja Nagy, Josef M. Penninger. The RANKL-RANK Story. Gerontology 2015; 61(6): 534 doi: 10.1159/000371845
|
5 |
Roberto Ria, Antonio Solimando, Assunta Melaccio, Azzurra Sportelli, Angelo Vacca. Update on Multiple Myeloma. 2019; doi: 10.5772/intechopen.76931
|
6 |
Antonio Garcia-Gomez, Javier Rodríguez-Ubreva, Esteban Ballestar. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment. Clinical Immunology 2018; 196: 64 doi: 10.1016/j.clim.2018.02.013
|
7 |
Mahmoud Dabbah, Oshrat Attar-Schneider, Victoria Zismanov, Shelly Tartakover Matalon, Michael Lishner, Liat Drucker. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation. Journal of Leukocyte Biology 2016; 100(4): 761 doi: 10.1189/jlb.3A1115-510RR
|
8 |
Abdelilah Mekhloufi, Andrea Kosta, Helena Stabile, Rosa Molfetta, Alessandra Zingoni, Alessandra Soriani, Marco Cippitelli, Rossella Paolini, Angela Gismondi, Maria Rosaria Ricciardi, Maria Teresa Petrucci, Laura Masuelli, Giulio Caracciolo, Sara Palchetti, Angela Santoni, Cinzia Fionda. Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor. Cancers 2020; 12(2): 440 doi: 10.3390/cancers12020440
|
9 |
Nikolaos Giannakoulas, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos. The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma. International Journal of Molecular Sciences 2021; 22(9): 4462 doi: 10.3390/ijms22094462
|
10 |
Heather Fairfield, Samantha Costa, Carolyne Falank, Mariah Farrell, Connor S. Murphy, Anastasia D’Amico, Heather Driscoll, Michaela R. Reagan. Multiple Myeloma Cells Alter Adipogenesis, Increase Senescence-Related and Inflammatory Gene Transcript Expression, and Alter Metabolism in Preadipocytes. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.584683
|
11 |
Antonio Garcia-Gomez, Tianlu Li, Carlos de la Calle-Fabregat, Javier Rodríguez-Ubreva, Laura Ciudad, Francesc Català-Moll, Gerard Godoy-Tena, Montserrat Martín-Sánchez, Laura San-Segundo, Sandra Muntión, Xabier Morales, Carlos Ortiz-de-Solórzano, Julen Oyarzabal, Edurne San José-Enériz, Manel Esteller, Xabier Agirre, Felipe Prosper, Mercedes Garayoa, Esteban Ballestar. Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease. Nature Communications 2021; 12(1) doi: 10.1038/s41467-020-20715-x
|
12 |
Haiying Wu, Yuanting Wu, Li Ren, Wo Zhai, Yuxia Jiang, Shuping Guo, Diehong Tao, Chuanyong Su, Zhilu Chen, Huifang Jiang. Effects of triptolide on bone marrow‑derived mesenchymal stem cells from patients with multiple myeloma. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7373
|
13 |
Thao M. Nguyen, Agnieszka Arthur, Stan Gronthos. The role of Eph/ephrin molecules in stromal–hematopoietic interactions. International Journal of Hematology 2016; 103(2): 145 doi: 10.1007/s12185-015-1886-x
|
14 |
Heather Fairfield, Carolyne Falank, Lindsey Avery, Michaela R. Reagan. Multiple myeloma in the marrow: pathogenesis and treatments. Annals of the New York Academy of Sciences 2016; 1364(1): 32 doi: 10.1111/nyas.13038
|
15 |
Matthew Ho, Chia Yin Goh, Ashish Patel, Susannah Staunton, Ronan O’Connor, Marc Godeau, Giada Bianchi. Role of the Bone Marrow Milieu in Multiple Myeloma Progression and Therapeutic Resistance. Clinical Lymphoma Myeloma and Leukemia 2020; 20(10): e752 doi: 10.1016/j.clml.2020.05.026
|
16 |
Connor M. D. Williams, Jacqueline E. Noll, Alanah L. Bradey, Jvaughn Duggan, Vicki J. Wilczek, Makutiro G. Masavuli, Branka Grubor‐Bauk, Romana A. Panagopoulos, Duncan R. Hewett, Krzysztof M. Mrozik, Andrew C. W. Zannettino, Kate Vandyke, Vasilios Panagopoulos. Myeloperoxidase creates a permissive microenvironmental niche for the progression of multiple myeloma. British Journal of Haematology 2023; 203(4): 614 doi: 10.1111/bjh.19102
|
17 |
A R Masters, L Haynes, D-M Su, D B Palmer. Immune senescence: significance of the stromal microenvironment. Clinical and Experimental Immunology 2016; 187(1): 6 doi: 10.1111/cei.12851
|
18 |
Siegfried Janz, Fenghuang Zhan, Fumou Sun, Yan Cheng, Michael Pisano, Ye Yang, Hartmut Goldschmidt, Parameswaran Hari. Germline Risk Contribution to Genomic Instability in Multiple Myeloma. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.00424
|
19 |
Sebastiano Giallongo, Andrea Duminuco, Ilaria Dulcamare, Tatiana Zuppelli, Enrico La Spina, Grazia Scandura, Annalisa Santisi, Alessandra Romano, Francesco Di Raimondo, Daniele Tibullo, Giuseppe A. Palumbo, Cesarina Giallongo. Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers. Biomolecules 2023; 13(12): 1701 doi: 10.3390/biom13121701
|
20 |
Lavinia Raimondi, Angela De Luca, Eugenio Morelli, Gianluca Giavaresi, Pierosandro Tagliaferri, Pierfrancesco Tassone, Nicola Amodio. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/6504593
|
21 |
Evgeniya V. Dolgova, Ekaterina Ya Shevela, Tamara V. Tyrinova, Alexandra M. Minkevich, Anastasia S. Proskurina, Ekaterina A. Potter, Konstantin E. Orishchenko, Evgeniy L. Zavjalov, Sergey I. Bayborodin, Valeriy P. Nikolin, Nelly A. Popova, Natalia V. Pronkina, Alexandr A. Ostanin, Elena R. Chernykh, Sergey S. Bogachev. Nonadherent Spheres With Multiple Myeloma Surface Markers Contain Cells that Contribute to Sphere Formation and Are Capable of Internalizing Extracellular Double-Stranded DNA. Clinical Lymphoma Myeloma and Leukemia 2016; 16(10): 563 doi: 10.1016/j.clml.2016.06.014
|
22 |
Javier Rodríguez-Ubreva, Antonio Garcia-Gomez, Esteban Ballestar. Epigenetic mechanisms of myeloid differentiation in the tumor microenvironment. Current Opinion in Pharmacology 2017; 35: 20 doi: 10.1016/j.coph.2017.04.008
|
23 |
Silvia Marino, Daniela N. Petrusca, G. David Roodman. Therapeutic targets in myeloma bone disease. British Journal of Pharmacology 2021; 178(9): 1907 doi: 10.1111/bph.14889
|
24 |
Chiara Valsecchi, Stefania Croce, Alice Maltese, Lorenza Montagna, Elisa Lenta, Alice Nevone, Maria Girelli, Paolo Milani, Tiziana Bosoni, Margherita Massa, Carlotta Abbà, Rita Campanelli, Jessica Ripepi, Annalisa De Silvestri, Adriana Carolei, Giovanni Palladini, Marco Zecca, Mario Nuvolone, Maria Antonietta Avanzini. Bone Marrow Microenvironment in Light-Chain Amyloidosis: In Vitro Expansion and Characterization of Mesenchymal Stromal Cells. Biomedicines 2021; 9(11): 1523 doi: 10.3390/biomedicines9111523
|
25 |
Nader Vazifeh Shiran, Saeid Abroun. Plasma Cell Proliferation Is Reduced in Myeloma-Induced Hypercalcemia and in Co-Culture with Normal Healthy BM-MSCs. Laboratory Medicine 2021; 52(3): 273 doi: 10.1093/labmed/lmaa060
|
26 |
Simone Pacini, Marina Montali, Francesco Mazziotta, Claudia P. Schifone, Lucia Macchia, Vittoria Carnicelli, Francesca M. Panvini, Serena Barachini, Laura Notarfranchi, Giovanni Battista Previti, Gabriele Buda, Mario Petrini. Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma. Oncotarget 2019; 10(63): 6781 doi: 10.18632/oncotarget.27285
|
27 |
Yao Yao, Yueyue Sun, Min Shi, Dandan Xia, Kai Zhao, Lingyu Zeng, Ruosi Yao, Ying Zhang, Zhenyu Li, Mingshan Niu, Kailin Xu. Piperlongumine induces apoptosis and reduces bortezomib resistance by inhibiting STAT3 in multiple myeloma cells. Oncotarget 2016; 7(45): 73497 doi: 10.18632/oncotarget.11988
|
28 |
Andrea Díaz-Tejedor, Mauro Lorenzo-Mohamed, Noemí Puig, Ramón García-Sanz, María-Victoria Mateos, Mercedes Garayoa, Teresa Paíno. Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression. Cancers 2021; 13(6): 1353 doi: 10.3390/cancers13061353
|
29 |
Yuanyi Zhang, Yan Qi, Yang Zhao, Hongyan Sun, Jingyan Ge, Zhonghui Liu. Activin A induces apoptosis of mouse myeloma cells via the mitochondrial pathway. Oncology Letters 2017; doi: 10.3892/ol.2017.7584
|
30 |
Carmen Muñiz, Cristina Teodosio, Andrea Mayado, Ana Teresa Amaral, Sergio Matarraz, Paloma Bárcena, Maria Luz Sanchez, Iván Alvarez-Twose, María Diez-Campelo, Andrés C. García-Montero, Juan F. Blanco, Maria Consuelo Del Cañizo, Javier del Pino Montes, Alberto Orfao. Ex vivo identification and characterization of a population of CD13high CD105+ CD45− mesenchymal stem cells in human bone marrow. Stem Cell Research & Therapy 2015; 6(1) doi: 10.1186/s13287-015-0152-8
|